Brenneman DE - Search Results

1

Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, Gozes I. Brenneman DE, et al. J Pharmacol Exp Ther. 1998 May;285(2):619-27. J Pharmacol Exp Ther. 1998. PMID: 9580606

2

Protective peptides that are orally active and mechanistically nonchiral.

Brenneman DE, Spong CY, Hauser JM, Abebe D, Pinhasov A, Golian T, Gozes I. Brenneman DE, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):1190-7. doi: 10.1124/jpet.103.063891. Epub 2004 Mar 8. J Pharmacol Exp Ther. 2004. PMID: 15007105

3

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, Brenneman DE. Gozes I, et al. Among authors: brenneman de. J Pharmacol Exp Ther. 1991 Jun;257(3):959-66. J Pharmacol Exp Ther. 1991. PMID: 1646331

4

Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.

Gozes I, Lilling G, Glazer R, Ticher A, Ashkenazi IE, Davidson A, Rubinraut S, Fridkin M, Brenneman DE. Gozes I, et al. Among authors: brenneman de. J Pharmacol Exp Ther. 1995 Apr;273(1):161-7. J Pharmacol Exp Ther. 1995. PMID: 7714762

5

A femtomolar-acting neuroprotective peptide.

Brenneman DE, Gozes I. Brenneman DE, et al. J Clin Invest. 1996 May 15;97(10):2299-307. doi: 10.1172/JCI118672. J Clin Invest. 1996. PMID: 8636410 Free PMC article.

6

VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.

Brenneman DE, Glazner G, Hill JM, Hauser J, Davidson A, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1998 Dec 11;865:207-12. doi: 10.1111/j.1749-6632.1998.tb11180.x. Ann N Y Acad Sci. 1998. PMID: 9928014 Review.

7

Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism.

Brenneman DE, Hauser J, Phillips TM, Davidson A, Bassan M, Gozes I. Brenneman DE, et al. Ann N Y Acad Sci. 1999;897:17-26. doi: 10.1111/j.1749-6632.1999.tb07875.x. Ann N Y Acad Sci. 1999. PMID: 10676432 Review.

8

Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze.

Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE. Gozes I, et al. Among authors: brenneman de. J Pharmacol Exp Ther. 2000 Jun;293(3):1091-8. J Pharmacol Exp Ther. 2000. PMID: 10869414

9

Protective peptides derived from novel glial proteins.

Brenneman DE, Spong CY, Gozes I. Brenneman DE, et al. Biochem Soc Trans. 2000;28(4):452-5. Biochem Soc Trans. 2000. PMID: 10961938 Review.

10

Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.

Spong CY, Abebe DT, Gozes I, Brenneman DE, Hill JM. Spong CY, et al. Among authors: brenneman de. J Pharmacol Exp Ther. 2001 May;297(2):774-9. J Pharmacol Exp Ther. 2001. PMID: 11303069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters